Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure: Results from The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

1. Silva-Fernández, L.
2. De Cock, D.
3. Lunt, M.
4. Low, A.S.
5. Watson, K.D.
6. Symmons, D.P.M.
7. Hyrich, K.L.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1093/RHEUMATOLOGY/KEX304 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus